Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if injections of rhuFab V2 into the eye in
combination with verteporfin photodynamic therapy (PDT) is a safe and efficacious treatment
for patients with age-related macular degeneration.